Johnson & Johnson reported Q4 revenues of $17.558 billion versus an estimate of $17.667 billion, and the company's 2013 guidance also came in lower than expected. Catherine Arnold, Credit Suisse senior analyst, offers insight.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT